50
Participants
Start Date
March 9, 2021
Primary Completion Date
February 21, 2023
Study Completion Date
April 12, 2023
To assess the clinical impact of dosing acyclovir based on IBW or adjBW for HSV encephalitis to definitively guide safe and effective therapy.
The study center utilize Epic ® electronic health record (Verona, Wisconsin; www.epic.com) for which all data will be extracted from. Each study center will obtain individual IRB approval prior to data collection. SSM - St. Clare will serve as the lead center for the study with all other centers sending collected and de-identified data to this central site for analysis.
Methodist Charlton Medical Center, Dallas
Methodist Health System
OTHER